Miromatrix Medical Valuation
| MIRODelisted Stock | USD 1.49 0.22 12.87% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Miromatrix Medical secures a last-minute Real Value of $1.26 per share. The latest price of the firm is $1.49. Our model forecasts the value of Miromatrix Medical from analyzing the firm fundamentals such as Shares Outstanding of 27.42 M, operating margin of (593.69) %, and Return On Equity of -1.14 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Miromatrix Medical's price fluctuation is very steady at this time. Calculation of the real value of Miromatrix Medical is based on 3 months time horizon. Increasing Miromatrix Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Miromatrix Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Miromatrix Stock. However, Miromatrix Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.49 | Real 1.26 | Hype 1.49 |
The intrinsic value of Miromatrix Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Miromatrix Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Miromatrix Medical helps investors to forecast how Miromatrix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Miromatrix Medical more accurately as focusing exclusively on Miromatrix Medical's fundamentals will not take into account other important factors: Miromatrix Medical Total Value Analysis
Miromatrix Medical is now projected to have valuation of 80.11 M with market capitalization of 92.95 M, debt of 3.55 M, and cash on hands of 32.67 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Miromatrix Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
80.11 M | 92.95 M | 3.55 M | 32.67 M |
Miromatrix Medical Investor Information
About 24.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.14. Miromatrix Medical had not issued any dividends in recent years. Based on the analysis of Miromatrix Medical's profitability, liquidity, and operating efficiency, Miromatrix Medical is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Miromatrix Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Miromatrix Medical has an asset utilization ratio of 2.74 percent. This suggests that the Company is making $0.0274 for each dollar of assets. An increasing asset utilization means that Miromatrix Medical is more efficient with each dollar of assets it utilizes for everyday operations.Miromatrix Medical Ownership Allocation
Miromatrix Medical maintains a total of 27.42 Million outstanding shares. Miromatrix Medical holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Miromatrix Medical Profitability Analysis
The company reported the previous year's revenue of 953.47 K. Net Loss for the year was (29.96 M) with loss before overhead, payroll, taxes, and interest of (466.93 K).About Miromatrix Medical Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Miromatrix Medical. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Miromatrix Medical based exclusively on its fundamental and basic technical indicators. By analyzing Miromatrix Medical's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Miromatrix Medical's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Miromatrix Medical. We calculate exposure to Miromatrix Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Miromatrix Medical's related companies.Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota. Miromatrix Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people.
Miromatrix Medical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 20.7 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Miromatrix Stock
If you are still planning to invest in Miromatrix Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Miromatrix Medical's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |